AzTrials
AzTrials

Type 2 DiabetesBortner PiedNCT04159922

Study of the Psychological Profile of Type 2 Diabetic Patients With Foot Wounds, Compared to Diabetic Patients Without Foot Wounds

An observational study of Type 2 Diabetes and Foot Wound, run by Centre Hospitalier Universitaire Dijon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Several studies have highlighted the value of analyzing a patient's psychological profile with the Bortner scale questionnaire (defined as type A or B personality). This analysis helps to better understand and anticipate patients' behaviour, stress and compliance with their disease and its progression. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Type 2 Diabetes, Foot Wound
What is being tested?
questionnaire
How many people
66 participants
Where
1 siteFrance
Study dates
3 Dec 2019to 18 Feb 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients with type 2 diabetes with foot wounds

Who may be able to join

  • diagnosis of type 2 diabetes
  • patient > 18 years old
  • with a diabetic foot wound
  • person who has expressed non-opposiyion to participation in the study

Who cannot join

  • a person who is not affiliated to national health insurance
  • person subject to legal protection (curatorship, guardianship)
  • person under limited judicial protection
  • pregnant, parturient or breastfeeding woman
  • adult unable to consent
  • minor

Trial locations and contacts

1 site in 1 country.

France1 site
  • Chu Dijon Bourogne

    Dijon, 21079

Other trials in France

About this study

Several studies have highlighted the value of analyzing a patient's psychological profile with the Bortner scale questionnaire (defined as type A or B personality). This analysis helps to better understand and anticipate patients' behaviour, stress and compliance with their disease and its progression. The Type A personality profile combines hyperactivity, competitiveness and exaggerated ambition, while the B profile is characterized by lower sensitivity to stress and reduced competitiveness.

It has been shown that the type B psychological profile in patients with type 2 diabetes is an independent risk factor for inflammation and that, in type 1 diabetes, the type A psychological profile is associated with a decrease in the expression of the pro-inflammatory cFos gene.

Read more

Thus, the psychological profile appears to have an impact not only on the patient's behaviour but also on his or her biology.

It has never been determined whether the type A or B psychological profile assessed by Bortner's self-administered questionnaire can influence the development of foot wounds in patients with type 2 diabetes who often have a medically unfavourable prognosis and socio-economic difficulties. We would therefore like to study the psychological profile of these individuals in order to make comparisons with the data obtained in a previous study that included patients with type 2 diabetes who did not have a foot wound.

Being tested
questionnaire
Medical subject headings
Diabetes Mellitus, Type 2, Foot Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • questionnaireOther

    Bortner self questionnaire: 14 items Cohen PSS Perceived Stress scale: 10 items quality of life scale: 32 items depression scale: 14 items

Study groups in NCT04159922
Study groupRoleWhat they receive
Type 2 diabetic patients with foot woundsNot described
Receives: Other: questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Score of the Bortner self-questionnaire

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Nov 2019
  2. Study start3 Dec 2019
  3. Primary completion18 Feb 2020
  4. Study completion18 Feb 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
66 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04159922
Sponsor's protocol ID
VERGES 2019
Acronym
Bortner Pied
Status last verified
Jan 2026
First submitted
8 Nov 2019
Last updated
3 Feb 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Verges B, Brands R, Fourmont C, Petit JM, Simoneau I, Rouland A, Legris P, Bouillet B, Chauvet-Gelinier JC. Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer. Diabetes Metab. 2021 Nov;47(6):101245. doi: 10.1016/j.diabet.2021.101245. Epub 2021 Mar 12.

    PubMed 33722768

Questions about this trial

What is this clinical trial studying?

An observational study of Type 2 Diabetes and Foot Wound, run by Centre Hospitalier Universitaire Dijon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Score of the Bortner self-questionnaire (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04159922, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in